Robotic Cardiac Compression Device Using Artificial Muscle Filaments for the Treatment of Heart Failure

Author:

Phan Phuoc Thien1,Davies James1,Hoang Trung Thien1,Thai Mai Thanh12,Nguyen Chi Cong1,Ji Adrienne1,Zhu Kefan1,Sharma Bibhu1,Nicotra Emanuele1,Hayward Christopher34,Phan Hoang-Phuong56,Lovell Nigel. H.16,Do Thanh Nho16ORCID

Affiliation:

1. Graduate School of Biomedical Engineering Faculty of Engineering University of New South Wales (UNSW) Sydney NSW 2052 Australia

2. College of Engineering and Computer Science Vin University Hanoi 12400 Vietnam

3. Department of Cardiology St Vincent's Hospital Sydney NSW 2010 Australia

4. St Vincent's Clinical School Faculty of Medicine UNSW Sydney NSW 2052 Australia

5. School of Mechanical and Manufacturing Engineering Faculty of Engineering UNSW Sydney NSW 2052 Australia

6. Tyree Foundation Institute of Health Engineering (IHealthE) UNSW Sydney NSW 2052 Australia

Abstract

Heart failure occurs when the heart cannot pump adequate blood to the body, which afflicts over 60 million people worldwide. Its treatment options include physiotherapy, medication, mechanical heart support, heart surgery, or heart transplantation. Ventricular assist devices have direct blood contact while passive ventricular constraint devices have only modest therapeutic efficacy. Current direct cardiac compression devices are either bulky, require noisy driving pneumatic sources, or are unable to mimic the natural heart motion. This study introduces a robotic cardiac compression device made of soft artificial muscle filaments that can simultaneously produce radial, axial, and torsional movements, potentially augmenting the pumping function of a failing heart. An empirical model is developed to describe the device motion and an artificial pericardium is employed to enable uniform force distribution to the heart and real‐time pressure sensing. The proposed device could deliver a stroke volume of 70 mL at 15 beats per minute, or a cardiac output of 1.05 L min−1, and achieve a peak instantaneous flow rate of 2.8 L min−1 and an output pressure of 50 mmHg. The new devices are highly customizable and experimentally validated with fresh porcine heart. They are expected to inspire future development of nonblood‐contacting cardiac assist devices.

Funder

National Heart Foundation of Australia

Publisher

Wiley

Subject

General Medicine

Reference76 articles.

1. Epidemiology of heart failure

2. E. T.Roche M. A.Horvath A.Alazmani K. C.Galloway N. V.Vasilyev D. J.Mooney F. A.Pigula C. J.Walsh presented atASME 2015 Int. Design Engineering Technical Conf. and Computers and Information in Engineering Conf. ASME Boston MA2015.

3. What is heart failure?https://www.heartfoundation.org.au/Bundles/Your-heart/heart-failure (accessed: 2023).

4. Heart failure drug treatment

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3